6342-19-4 Usage
Uses
Used in Pharmaceutical Industry:
Morpholin-4-yl-phenyl-acetic acid is used as a key intermediate for the synthesis of various pharmaceuticals and drugs. Its unique chemical structure and properties allow it to modulate specific biological pathways, making it a promising candidate for drug design and discovery.
Used in Advanced Materials Production:
MORPHOLIN-4-YL-PHENYL-ACETIC ACID is utilized as a building block in the production of advanced materials, where its versatile chemical properties contribute to the development of innovative and high-performance materials.
Used in Agrochemical Industry:
Morpholin-4-yl-phenyl-acetic acid is employed as a key intermediate in the synthesis of agrochemicals, playing a crucial role in the development of effective and environmentally friendly agricultural products.
Used in Specialty Chemicals Production:
It is also used as a building block in the production of specialty chemicals, where its unique structure and properties contribute to the creation of high-quality and specialized chemical products for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 6342-19-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,4 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6342-19:
(6*6)+(5*3)+(4*4)+(3*2)+(2*1)+(1*9)=84
84 % 10 = 4
So 6342-19-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO3/c14-12(15)11(10-4-2-1-3-5-10)13-6-8-16-9-7-13/h1-5,11H,6-9H2,(H,14,15)
6342-19-4Relevant academic research and scientific papers
Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators
Charton, Julie,Girault-Mizzi, Sophie,Debreu-Fontaine, Marie-Ange,Foufelle, Fabienne,Hainault, Isabelle,Bizot-Espiard, Jean-Guy,Caignard, Daniel-Henri,Sergheraert, Christian
, p. 4490 - 4518 (2007/10/03)
Design, synthesis and structure-activity relationships of benzimidazole derivatives as activators of the AMP-activated protein kinase (AMPK) are presented in this paper. AMPK is the central component of a protein kinase cascade that plays a key role in the regulation of energy balance. Once activated, AMPK initiates a series of responses that are aimed at restoring the energy balance of the cell and recent studies have indicated that AMPK plays an important role in regulation of the whole-body energy metabolism. The following study based on the lead compound S27847 involved modification of three regions of this compound. Preliminary structure-activity relationships are being described.
